malondialdehyde has been researched along with Pseudomonas Infections in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 9 (52.94) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Bose, SK; Chhibber, S; Harjai, K; Sharma, K | 1 |
Gupta, P; Gupta, RK; Harjai, K | 1 |
Chhibber, S; Gupta, P; Harjai, K | 1 |
Antus, B; Barta, I; Drozdovszky, O; Kelemen, K | 1 |
Armaganidis, A; Dimopoulos, G; Giamarellos-Bourboulis, EJ; Lignos, M; Theodorakopoulou, M; Tsaganos, T; Tzepi, IM | 1 |
Aggarwal, S; Chhibber, S; Harjai, K; Mittal, R; Sharma, S | 1 |
Chhibber, S; Harjai, K; Mittal, R; Sharma, S | 1 |
Giamarellos-Bourboulis, EJ; Kotsaki, A; Polychronopoulos, V; Spyridaki, A; Tsaganos, T; Tsovolou, I; Tzepi, I; Vaki, I | 1 |
Cox, RA; Enkhbaatar, P; Hamahata, A; Herndon, DN; Horvath, E; Lange, M; Nakano, Y; Schmalstieg, FC; Szabo, C; Traber, DL; Traber, LD | 1 |
Adamis, T; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Koussoulas, V; Laoutaris, G; Mouktaroudi, M; Perrea, D; Sabracos, L | 1 |
Bolanos, N; Dionyssiou-Asteriou, A; Dontas, I; Galani, I; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kousoulas, V; Plachouras, D; Raftogiannis, M; Tzivra, A | 1 |
Burke, AS; Cox, RA; Enkhbaatar, P; Hawkins, HK; Komjáti, K; Mabley, JG; Murakami, K; Pacher, P; Salzman, AL; Schmalstieg, FC; Shimoda, K; Szabó, C; Traber, DL; Traber, LD; Zsengellér, Z | 1 |
Adamis, T; Baziaka, F; Giamarellos-Bourboulis, EJ; Katsambas, AD; Kavatzas, N; Mouktaroudi, M; Petropoulou, H; Stavrianeas, NG; Stratigos, A | 1 |
Kapranov, NI; Kashirskaia, NIu; Pukhal'skiĭ, AL; Shmarina, GV | 1 |
Adamis, T; Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koussoulas, V; Mouktaroudi, M; Perrea, D; Sabracos, L | 1 |
Adamis, T; Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koutoukas, P; Panagou, C; Raftogiannis, M; Tsaganos, T; Tziortzioti, V | 1 |
Barber, AE; Fahey, TJ; Jones, WG; Minei, JP; Shires, GT | 1 |
17 other study(ies) available for malondialdehyde and Pseudomonas Infections
Article | Year |
---|---|
Exploring the Therapeutic Efficacy of Zingerone Nanoparticles in Treating Biofilm-Associated Pyelonephritis Caused by Pseudomonas aeruginosa in the Murine Model.
Topics: Animals; Biofilms; Disease Models, Animal; Guaiacol; HEK293 Cells; Humans; Inflammation; Malondialdehyde; Mice; Microscopy, Electron, Scanning; Nanoparticles; Peroxidase; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Stem Cells; Tetrazolium Salts; Thiazoles | 2020 |
Quorum sensing signal molecules produced by Pseudomonas aeruginosa cause inflammation and escape host factors in murine model of urinary tract infection.
Topics: Animals; Bacterial Adhesion; Female; Inflammation; Malondialdehyde; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Quorum Sensing; Reactive Nitrogen Species; Signal Transduction; Urinary Tract; Urinary Tract Infections | 2013 |
Efficacy of purified lactonase and ciprofloxacin in preventing systemic spread of Pseudomonas aeruginosa in murine burn wound model.
Topics: Animals; Anti-Bacterial Agents; Burns; Chemokine CXCL2; Ciprofloxacin; Disease Models, Animal; Interleukin-10; Interleukin-6; Malondialdehyde; Metalloendopeptidases; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Reactive Nitrogen Species; Virulence; Wound Infection | 2015 |
Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis.
Topics: Adult; Area Under Curve; Breath Tests; Case-Control Studies; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Malondialdehyde; Neutrophils; Nitric Oxide; Oxidative Stress; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; ROC Curve; Sputum; Young Adult | 2015 |
Esmolol: immunomodulator in pyelonephritis by Pseudomonas aeruginosa.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunologic Factors; Male; Malondialdehyde; Propanolamines; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits | 2015 |
Contribution of macrophage secretory products to urovirulence of Pseudomonas aeruginosa.
Topics: Analysis of Variance; Animals; Biofilms; Cell Proliferation; Disease Models, Animal; Female; Histocytochemistry; Kidney; Macrophages, Peritoneal; Malondialdehyde; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Urinary Bladder; Urinary Tract Infections; Virulence | 2009 |
Evaluation of interleukin-10 production in Pseudomonas aeruginosa induced acute pyelonephritis.
Topics: Analysis of Variance; Animals; Biofilms; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Euthanasia, Animal; Humans; Interleukin-10; Kidney; Malondialdehyde; Mice; Neutrophils; Plankton; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis | 2009 |
Impact of multidrug resistance on experimental empyema by Pseudomonas aeruginosa.
Topics: Animals; Bacterial Load; Cytokines; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Empyema; Humans; Immunity, Innate; Lung; Male; Malondialdehyde; Monocytes; Neutrophils; Pleural Effusion; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Species Specificity; Survival Rate; Tumor Necrosis Factor-alpha; U937 Cells; Virulence | 2011 |
Time profile of oxidative stress and neutrophil activation in ovine acute lung injury and sepsis.
Topics: Acute Lung Injury; Animals; Disease Models, Animal; Gene Expression Regulation; Inflammation Mediators; Interleukin-6; Lung; Malondialdehyde; Neutrophil Activation; Neutrophils; Oxidative Stress; Peroxidase; Poly Adenosine Diphosphate Ribose; Pseudomonas aeruginosa; Pseudomonas Infections; Sheep; Smoke Inhalation Injury; Time Factors | 2012 |
Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa.
Topics: Acute Disease; Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Immunity; Lipopolysaccharides; Male; Malondialdehyde; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits; Sepsis; Survival Analysis; Tumor Necrosis Factor-alpha | 2004 |
Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study.
Topics: Animals; Anti-Bacterial Agents; Calcitonin; Calcitonin Gene-Related Peptide; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Immunity, Innate; Immunoenzyme Techniques; Interleukins; Luminescent Measurements; Male; Malondialdehyde; Monocytes; Protein Precursors; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2004 |
Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis.
Topics: Animals; Antithrombins; DNA Damage; Enzyme Inhibitors; Female; Hematocrit; Hemoglobins; Immunohistochemistry; Indoles; Lipid Peroxidation; Lung; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Poly(ADP-ribose) Polymerase Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sepsis; Sheep; Time Factors; Tyrosine | 2004 |
Early cutaneous alterations in experimental sepsis by Pseudomonas aeruginosa.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Bacteremia; Biopsy, Needle; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Immunohistochemistry; Inflammation Mediators; Male; Malondialdehyde; Probability; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Severity of Illness Index; Skin; Survival Rate; Tumor Necrosis Factor-alpha | 2004 |
[Dynamics of markers of blood inflammation against the background of antibacterial therapy in children with mucoviscidosis, with the various regimens of intake of pancreatic enzymes].
Topics: Adolescent; Anti-Bacterial Agents; Biomarkers; Child; Cystic Fibrosis; Enzyme Therapy; Female; Humans; Inflammation; Inflammation Mediators; Lymphocyte Activation; Lymphocytes; Male; Malondialdehyde; Oxidative Stress; Pancreas; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum | 2004 |
The significance of oxidant/antioxidant balance for the pathogenesis of experimental sepsis by multidrug-resistant Pseudomonas aeruginosa.
Topics: Animals; Drug Resistance, Multiple, Bacterial; Lipid Peroxidation; Lipopolysaccharides; Male; Malondialdehyde; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis; Tumor Necrosis Factor-alpha | 2005 |
Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Immunologic Factors; Kidney; Lipopolysaccharides; Liver; Lung; Male; Malondialdehyde; Monocytes; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Rabbits; Spleen; Tumor Necrosis Factor-alpha | 2006 |
Differential pathophysiology of bacterial translocation after thermal injury and sepsis.
Topics: Animals; Biopsy; Body Water; Body Weight; Burns; Cell Membrane Permeability; Disease Models, Animal; Enterobacteriaceae; Gastrointestinal Diseases; Ileum; Intestinal Absorption; Ischemia; Lipid Peroxidation; Male; Malondialdehyde; Organ Size; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis | 1991 |